Cargando…
High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease
BACKGROUND AND AIM: While weight gain during infliximab therapy in inflammatory bowel disease (IBD) is common, there has been limited research evaluating its impact on infliximab efficacy. METHODS: Primary aims of this study were to determine the frequency of excess weight gain (body mass index [BMI...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273726/ https://www.ncbi.nlm.nih.gov/pubmed/32514452 http://dx.doi.org/10.1002/jgh3.12277 |